glp 1 oral drug With FDA approval of Wegovy pill, new era of GLP-1 weight loss drugs begins GLP-1 drugs: Lower dose or

Graphical abstract Table 1

Food logging sits beside shot or pill timing, injection-site history, side effects, protein, fiber, water, weight, progress photos, medication context, Journey Card, and Capy because the point is not to count food in isolation

Med 89 , 457464 (2022)

In June 2025, MBX Biosciences announced that it has submitted an IND application to the FDA for MBX 4291, a long-acting GLP-1/GIP receptor co-agonist prodrug targeting obesity, which received regulatory clearance in July

Harrison SA, Browne SK, Suschak JJ, et al

Footnotes CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was reported